Literature DB >> 26269533

The influence of needle gauge and infection source on vitreous aspirate cultures.

Jesse M Smith1, Marc T Mathias1, Scott C Oliver1, Naresh Mandava1, Jeffrey L Olson1, Hugo Quiroz-Mercado1, Alan G Palestine1.   

Abstract

BACKGROUND/AIMS: While the Endophthalmitis Vitrectomy Study (EVS) included only post-cataract surgery patients, the methods and data from that study are widely applied in the management of endophthalmitis of all types. We sought to examine how our experience with in-office vitreous aspiration differed from the EVS in two ways: first, by reviewing microbiological culture yields from vitreous aspirates obtained using 30-gauge needles versus 25-27-gauge needles and second, by reviewing culture yields in cases of endogenous versus non-endogenous endophthalmitis.
METHODS: Cases of endophthalmitis over a 14-year period were reviewed when vitreous tap was the initial diagnostic procedure. The data included infection source, needle size used to obtain a vitreous aspirate, organism cultured and rates of unsuccessful attempts at vitreous aspiration or dry taps.
RESULTS: 10 cases were endogenous endophthalmitis, while 36 cases were a mix of postoperative, post-traumatic, post-intravitreal injection and miscellaneous patients. A positive microbiological culture was obtained in 11/36 (31%) of vitreous taps using a 25-27-gauge needle and in 8/10 (80%) taps using a 30-gauge needle (p<0.01). A positive vitreous culture was obtained in 18/36 (50%) of all non-endogenous cases, while a positive result was obtained in 0/10 (0%) cases of endogenous endophthalmitis (p<0.01).
CONCLUSIONS: The use of a smaller needle in obtaining vitreous samples in endophthalmitis did not lower the microbiological yield. A positive microbiological yield was significantly less likely in cases of endogenous endophthalmitis compared with non-endogenous cases. Vitreous tap as a method for identifying the causative organism in endogenous endophthalmitis was of limited utility. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Infection; Inflammation; Microbiology; Treatment Medical; Vitreous

Mesh:

Substances:

Year:  2015        PMID: 26269533     DOI: 10.1136/bjophthalmol-2015-307081

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Trends in treatment strategies for suspected bacterial endophthalmitis.

Authors:  Greg D Fliney; Paula E Pecen; Jennifer N Cathcart; Alan G Palestine
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-07       Impact factor: 3.117

2.  Impurities in Drug Vials Intended for Intravitreal Medication.

Authors:  Lisa Pohl; Lisa Strudel; Spyridon Dimopoulos; Focke Ziemssen
Journal:  Case Rep Ophthalmol Med       Date:  2020-12-02

3.  Central Pars Plana Vitrectomy + Phacoemulsification + Intraocular Lens Implantation in Patients with Small Eyes, Cataract, and Narrow Anterior Chambers.

Authors:  Fermín Silva Cayatopa; Ana Luisa González Méndez; Robinson Barrientos Ortiz; Alejandro Silva Diaz; Fernando Godin Estrada
Journal:  Clin Ophthalmol       Date:  2021-10-19

4.  Pars-plana fluid aspiration for positive vitreous cavity pressure in anterior segment surgeries.

Authors:  Thomas Kuriakose; Smitha Jasper; Sherina Thomas
Journal:  Indian J Ophthalmol       Date:  2018-04       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.